BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/19/2025 8:44:10 AM | Browse: 2 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 110590
Country China
Category Endocrinology & Metabolism
Manuscript Type Retrospective Study
Article Title Indirect bilirubin is inversely associated with diabetic retinopathy risk and is a potential predictive biomarker
Manuscript Source Unsolicited Manuscript
All Author List Xiao-Ying Lin, Yi-Xuan Zheng, Meng-Meng Liu, Qian Liang, Meng Li, Jing Sui, Wei Qiang, Hui Guo, Bing-Yin Shi and Ming-Qian He
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of Shaanxi Province 2024JC-YBQN-0828
Natural Science Foundation of Shaanxi Province 2024JC-YBMS-765
Clinical Research Award of the First Affiliated Hospital of Xi'an Jiaotong University XJTU1AF-CRF-2022-036
National Innovation Center for Advanced Medical Devices NMED2023AGP-013
Corresponding Author Ming-Qian He, MD, Department of Endocrinology, The First Affiliated Hospital of Xi’an Jiaotong University, No.277 Yanta West Road, Xi’an 710061, Shaanxi Province, China. mingqian_he@xjtufh.edu.cn
Key Words Biomarker; Diabetic retinopathy; Indirect bilirubin; Oxidative stress; Type 2 diabetes mellitus
Core Tip This cross-sectional study distinguished the role of indirect bilirubin (IBIL) in diabetic retinopathy (DR) risk in patients with type 2 diabetes mellitus. IBIL levels were independently associated with a lower risk of developing DR, whereas total bilirubin and direct bilirubin were not. The optimal IBIL cutoff point for the risk of developing DR was 0.735 μmol/dL, with an area under the curve (AUC) of 0.612 in the overall population. The optimal IBIL cutoff point in male patients with elevated diastolic blood pressure was 0.655 μmol/dL, with an increased AUC of 0.662. IBIL is thus a potential predictive biomarker for DR.
Citation Lin XY, Zheng YX, Liu MM, Liang Q, Li M, Sui J, Qiang W, Guo H, Shi BY, He MQ. Indirect bilirubin is inversely associated with diabetic retinopathy risk and is a potential predictive biomarker. World J Diabetes 2025; In press
Received
2025-06-12 04:04
Peer-Review Started
2025-06-13 00:18
To Make the First Decision
Return for Revision
2025-06-27 02:15
Revised
2025-07-10 14:23
Second Decision
2025-08-08 09:21
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-08-19 08:44
Articles in Press
2025-08-19 08:44
Publication Fee Transferred
2025-07-17 14:57
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com